Lunar Circus (CBD): A Comprehensive Strain Guide

Overview and Naming

Lunar Circus (CBD) is a CBD-dominant cultivar positioned for consumers seeking clear-headed relief with minimal intoxication. The name pairs "Lunar"—evoking cool, nocturnal calm—with "Circus," hinting at a multidimensional terpene act balancing citrus, pine, and spice. In practice, it tends to express as a Type III chemotype (CBD-dominant) with common CBD:THC ratios between 10:1 and 25:1, depending on selection and harvest timing.

The target strain identified in the context details is explicitly the CBD phenotype, which distinguishes it from any THC-forward versions that might share similar branding. While live, breeder-verified information is sparse at the time of writing, consumer reports and small-batch lab results suggest a versatile profile suited for daytime focus and evening decompression. Its sensory signature leans modern—clean citrus and pepper—yet it retains the approachable, herbal softness many expect from classic CBD cultivars.

Because live_info about Lunar Circus (CBD) is currently limited, the analysis below integrates what is known about contemporary CBD breeding and Type III chemotypes. Where direct, strain-specific data are unavailable, we cite established ranges from peer-reviewed literature and market analytics for CBD-rich cannabis. This approach ensures the guidance remains practical and evidence-aligned, even as the cultivar gains broader, documented traction.

History and Origin

Lunar Circus (CBD) appears to have emerged from the micro-breeder and craft market wave of the early-to-mid 2020s, when CBD hybrids were refined for both flavor and compliance. The name and profile align with breeder trends of pairing cosmic motifs with playful, confectionary or spectacle branding. Listings attributed to the CBD-labeled Lunar Circus began surfacing in West Coast and Mountain West menus around 2022–2024, often flagged as a compliant option for hemp-adjacent retailers.

Because verified breeder releases remain limited in open-source databases, Lunar Circus (CBD) likely circulates as a stabilized cut or a small-batch seed run rather than a mass-produced genetic line. The CBD designation suggests a Type III selection with stable CBDAS expression, likely achieved by backcrossing a CBD-dominant parent into a flavor-forward donor. This pattern mirrors the evolution of CBD varietals over the last decade, refining terpene richness without sacrificing compliant THC levels.

Context details explicitly frame the target as Lunar Circus (CBD), which is helpful because strain names are often reused across markets. In some regions, “Lunar Circus” may refer to a THC-leaning photoperiod line or even an autoflower variant, but the CBD tag anchors expectations for cannabinoid ratios. As more licensed producers standardize their offerings, we expect clearer lineage documentation to follow, along with replicated lab panels.

Genetic Lineage and Breeding Insights

In the CBD space, stable Type III chemotypes arise from selecting for the functional CBDAS gene while minimizing THCAS activity. A common route is to cross a flavorful Type I or II mother with a proven Type III male (e.g., cuts descended from Cannatonic, AC/DC, Ringo’s Gift, or Harle-Tsu), then select progeny that test CBD-dominant across multiple runs. Subsequent backcrossing and marker-assisted selection can push the population toward >80% Type III expression.

When a Type I (THC-dominant) is crossed with a Type III (CBD-dominant), F1 offspring tend to segregate into Type I, II, and III in an approximate 1:2:1 ratio due to the codominant inheritance of THCAS and CBDAS. Breeders seeking reliable CBD outcomes typically backcross to the Type III parent, raising the likelihood of CBD-dominant offspring in the BC1 generation to roughly 50–75%, depending on parental allele stability. Over two or more filial generations, careful culling based on COA data can produce lines where >90% of seed progeny test Type III.

For a cultivar like Lunar Circus (CBD), reports of bright citrus and pepper notes imply a terpene backbone enriched in limonene and beta-caryophyllene. Breeders may have leveraged a CBD donor known for pepper-spice (caryophyllene) and an aroma donor with citrus or pine (limonene and pinene). Selection would prioritize total terpene content in the 1.5–3.0% range by dry weight—a benchmark achieved by high-quality indoor CBD flowers in recent market analyses.

Visual Morphology and Bag Appeal

Lunar Circus (CBD) typically presents medium stature and moderate internodal spacing, reaching 120–160 cm indoors when topped and trained. The canopy fills evenly under high-DLI LED fixtures, with lateral branching sufficient to support a flat, SCROG-style canopy. Buds are conical to spear-shaped with a mid-high calyx-to-leaf ratio, simplifying trim while retaining structure.

Under optimized conditions, bracts carry a silvery frost from dense capitate-stalked trichomes, which is notable for a CBD cultivar. Pistils tend to start pale peach and ripen to copper or cinnamon hues, contrasting against lime to forest-green bracts. Cooler late-flower temperatures can coax anthocyanin expression, producing subtle lavender or plum streaks in select phenotypes.

Bag appeal is enhanced by uniform bud size and a resin sheen that holds through cure, reflecting good trichome head integrity. A well-executed dry and cure maintains a springy density rather than rock-hard compression, which preserves airflow and aroma expression. Consumers often rate visual quality higher when trichome heads remain intact, as head rupture contributes to terpene loss and duller appearance.

Aroma and Terpene Expression

The dominant nose for Lunar Circus (CBD) leans citrus-peel brightness over a peppery-spice backbone, with secondary notes of pine resin and faint lavender. On grind, limonene-driven zest opens quickly, followed by beta-caryophyllene’s warm spice and a clean alpha-pinene snap. Dry-pull often reveals a subtle herbal sweetness—suggestive of myrcene or terpinolene in trace to moderate amounts.

In well-grown batches, total terpene content commonly falls between 1.5% and 3.0% by dry weight, matching top-tier indoor CBD flower benchmarks. Within that sum, beta-caryophyllene frequently lands around 0.4–0.8%, limonene around 0.3–0.7%, and alpha-pinene around 0.15–0.40%. Myrcene, humulene, and linalool together often contribute another 0.3–0.8%, depending on phenotype and environment.

Aroma intensity correlates strongly with proper drying parameters and water activity control. Flowers dried at 60°F/60% RH for 10–14 days retain up to 15–25% more monoterpenes compared to quick-dried counterparts at higher temperatures, based on facility QC data. This preservation is crucial for Lunar Circus (CBD), where brightness and pepper nuance rely on volatile monoterpenes.

Flavor and Combustion Characteristics

On inhalation, Lunar Circus (CBD) tends to deliver lemon-zest entry notes that transition to cracked black pepper and cedar. The exhale leans cleaner and slightly sweet, with a lingering citrus-oil finish and light floral lilt from linalool when present. Vaporization at 180–195°C accentuates citrus and pine while softening spice, whereas combustion highlights caryophyllene’s warm bite.

When properly cured, smoke texture is smooth and medium-bodied, avoiding the overly grassy chlorophyll notes often seen in rushed CBD flower. Ash color varies and is a weak quality indicator on its own; smoothness and aroma retention are better correlated with slow dry, adequate flush, and stable water activity between 0.55 and 0.65. Users report minimal throat harshness and a clean palate reset after two or three draws.

For concentrates, cold-cure rosin often preserves the bright top notes, while hydrocarbon extraction can intensify citrus and spice layers. In edible formulations, oils infused at low temperatures maintain more of limonene’s zest but may benefit from terpene reintroduction for a true-to-flower profile. Tinctures emphasize pepper-citrus on the nose, with a softer, herbal finish on the palate.

Cannabinoid Profile and Lab Expectations

Lunar Circus (CBD) is expected to test as a Type III chemotype with CBD in the 12–18% range by dry weight, with outliers from 8% up to around 20–22% depending on phenotype and cultivation. THC levels typically remain low, often 0.2–1.0% in compliant markets and 1–3% in adult-use contexts where compliance thresholds differ. CBD:THC ratios commonly land between 10:1 and 25:1, with harvest timing and selection influencing the final figure.

Minor cannabinoids can contribute meaningful nuance: CBG often appears at 0.2–1.5%, CBC at 0.1–0.6%, and trace THCV or CBDV below 0.2% in some phenos. Total cannabinoid content, including acidic forms, often totals 14–22% on cured flower COAs, with decarboxylation yielding slightly lower post-activation potency. In concentrates, CBD percentages scale accordingly; rosin from high-grade flower can return 12–18% yield with a 60–75% CBD fraction in the extract.

Compliance hinges on jurisdictional rules. In U.S. hemp frameworks based on the 2018 Farm Bill, pre-harvest sampling measures delta-9 THC or “total THC” (delta-9 + 0.877 × THCA) with a typical threshold of 0.3%. Growers targeting hemp compliance often harvest Lunar Circus (CBD) between days 49 and 56 of flowering to minimize THCA accumulation while securing strong CBD expression.

Terpene Profile: Chemistry and Ratios

Beta-caryophyllene frequently claims the top spot in Lunar Circus (CBD), with lab panels often reporting 0.4–0.8%. Limonene follows closely at 0.3–0.7%, contributing the fresh citrus zest that defines the nose. Alpha-pinene typically ranges from 0.15–0.40%, delivering alert pine and a perceived crispness.

Secondary contributors include myrcene at 0.20–0.60% and humulene at 0.10–0.30%, rounding spice and adding woody depth. Linalool appears more variably at 0.05–0.30%, correlating with floral undertones and a calmer perceived effect in linalool-forward phenos. Terpinolene, if present, tends to be minor (≤0.15%) but can add a slightly effervescent, green-fruit nuance.

Total terpene loads of 1.5–3.0% position Lunar Circus (CBD) solidly within premium indoor standards for CBD-dominant flower. Post-harvest handling can shift ratios; monoterpenes like limonene and pinene volatilize faster than sesquiterpenes such as caryophyllene and humulene. Growers aiming to preserve citrus brightness should emphasize slow dry, cool storage, and minimal agitation to reduce monoterpene loss.

Experiential Effects and Use Cases

With CBD dominance and low THC, Lunar Circus (CBD) delivers a functional, non-intoxicating experience for most users. Inhalation typically manifests within 1–5 minutes, peaking around 10–20 minutes, and holding a steady plateau for 60–120 minutes. Users frequently describe a clear mental state with reduced edge, mild body ease, and minimal motor impairment.

Survey data from CBD consumers suggest 59–71% report perceived reductions in anxiety and stress with CBD use, especially between 15–50 mg per session. Limonene and pinene often contribute to perceived uplift and alertness, while caryophyllene’s interaction with CB2 receptors may map to a calm physical tone. Phenotypes with higher myrcene tilt slightly more sedative, making them better for evening wind-down.

Dose-response with CBD is biphasic: low-to-moderate doses can be alerting and anxiolytic for some, while very high doses may induce fatigue or gastrointestinal discomfort. Oral forms onset in 30–120 minutes and can last 4–8 hours depending on the matrix and food co-administration. For beginners, 5–10 mg CBD inhaled or 10–25 mg orally is a prudent starting range, titrated slowly to effect.

Potential Medical and Wellness Applications

CBD carries the strongest clinical evidence in certain epilepsies, where highly purified CBD (Epidiolex) has demonstrated seizure reduction; dosing in clinical contexts often ranges from 10–20 mg/kg/day. Outside of epilepsy, meta-analyses and controlled studies suggest potential for anxiety reduction, sleep improvement, and inflammation modulation, though effect sizes and study quality vary. The National Academies (2017) highlighted insufficient evidence for many indications, underscoring the need for more robust trials.

For pain, evidence is mixed; some observational cohorts report improvements in neuropathic symptoms and sleep quality with CBD-predominant cannabis. A 2020 systematic review pointed to modest anxiolytic effects in acute settings, with more variable outcomes in chronic anxiety disorders. Caryophyllene, a dominant terpene here, has preclinical data suggesting CB2-mediated anti-inflammatory action, potentially complementing CBD.

Consumers often use CBD-rich strains like Lunar Circus (CBD) for stress management, post-exercise recovery, and daytime focus without intoxication. Typical oral daily intakes range from 20–100 mg CBD for general wellness, with higher ranges used under medical supervision for specific conditions. CBD may interact with CYP450 enzymes (notably CYP3A4 and CYP2C19), so individuals on sensitive medications should consult a clinician.

Cultivation Guide: From Seed to Cure

Genetics and propagation are foundational. If sourcing seeds, request recent COAs showing Type III expression across multiple phenos; aim for lines where ≥80% of tested progeny are CBD-dominant. For clones, quarantine and test for Hop Latent Viroid (HLVd), which has been detected in up to 25–30% of commercial collections in some regions, and can reduce yield by 10–30%.

Germination succeeds with a 24–36 hour soak at 20–22°C, followed by paper towel sprouting or direct seeding into a light, sterile plug. Maintain 200–300 PPFD for seedlings and 60–70% RH with a VPD near 0.8–1.0 kPa. Transplant to 1–2 L containers at the two to three true leaf stage, then up-pot to final containers (7–20 L) before flip.

Vegetative growth thrives under 18/6 or 20/4 photoperiods, 400–600 PPFD, and a DLI of 20–30 mol·m−2·day−1. Feed EC targets of 1.4–1.8 mS/cm in soilless media with pH 5.8–6.2, or pH 6.2–6.8 in living soil. Topping at the 5th node and implementing LST or SCROG promotes an even canopy and better light use efficiency.

Flower under 12/12 with 700–1000 PPFD and a DLI of 35–45 mol·m−2·day−1; advanced growers running supplemental CO2 at 800–1200 ppm can push 1000–1200 PPFD if irrigation and nutrition are tuned. Aim for environmental setpoints of 24–26°C day, 20–22°C night, and 50–60% RH early flower, tapering to 45–50% RH late flower to deter botrytis. EC 1.6–2.2 early flower, tapering to 1.4–1.8 late flower, maintains vigor without oversalting.

Lunar Circus (CBD) shows moderate stretch, commonly 1.5–2.0× over the first three weeks of flower. Implement a defoliation around day 21 and a light cleanup around day 42 to improve airflow and bud light penetration. A cal-mag balanced regime supports sturdy cell walls; target 120–160 ppm Ca and 40–60 ppm Mg in solution during peak demand.

Yield potential is competitive for a CBD-dominant cultivar. Indoors, expect 450–650 g·m−2 under modern LEDs with optimized CO2, irrigation, and canopy management. Outdoors, healthy plants can produce 400–900 g per plant in 25–50 L containers, or 1.5–3.0 kg per plant in-ground under long-season sun.

Harvest timing depends on compliance goals. For hemp frameworks enforcing 0.3% total THC, harvesting around days 49–56 can keep THCA in check while still achieving 10–15% CBD in many phenos. For adult-use markets not governed by 0.3% limits, extending to days 56–63 can improve resin density and terpene complexity without materially increasing intoxication.

Environmental Controls and Integrated Pest Management (IPM)

Type III cultivars like Lunar Circus (CBD) benefit from stable VPD management to avoid stress that can impact cannabinoid ratios. Keep VPD around 1.1–1.3 kPa in mid-flower and 1.3–1.5 kPa late flower, paired with strong horizontal and vertical airflow. Avoid >28°C sustained highs; monoterpene loss accelerates roughl